Worldwide

Abeona Therapeutics Inc. (NASDAQ:ABEO) Signals Intraday Volatility - Up by 1.44%

Abeona Therapeutics Inc. (NASDAQ:ABEO) Signals Intraday Volatility - Up by 1.44%”

Abeona Therapeutics Inc.is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. Two analysts have issued estimates for Abeona Therapeutics' earnings, with the lowest sales estimate coming in at $200,000.00 and the highest estimate coming in at $250,000.00. Highbridge Capital Management LLC raised its position in shares of Abeona Therapeutics by 23.5% in the first quarter. Highbridge Capital Management LLC increased its position in shares of Abeona Therapeutics by 23.5% during the 1st quarter. On average, equities research analysts anticipate that Abeona Therapeutics will post ($0.68) EPS for the current year.

Abeona Therapeutics (NASDAQ:ABEO) last issued its quarterly earnings results on Friday, March 31st. In the last earnings report the EPS was $-0.61 and is projected to be $-0.68 for the current year with 40,287,000 shares presently outstanding. The firm had revenue of $0.22 million during the quarter, compared to the consensus estimate of $0.21 million.

ABEO has been the subject of a number of research reports. Jefferies maintained the shares of ABEO in report on Thursday, April 27 with "Buy" rating. One equity analyst rating the company a strong buy, three equity analysts rating the company a buy, zero equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $12.38. Maxim Group reissued a buy rating and set a $14.00 price target on shares of Abeona Therapeutics in a research report on Wednesday, April 12th. Finally, BidaskClub downgraded Abeona Therapeutics from a "buy" rating to a "hold" rating in a research report on Wednesday, August 2nd.

The stock is trading at $17.65 a great deal higher than the 50 day moving average of $13.40 and which is impressively higher than the 200 day moving average of $8.08.

Several large investors have recently modified their holdings of ABEO. Wellington Management Group LLP grew its stake in shares of Abeona Therapeutics by 17.4% in the 1st quarter. Rhumbline Advisers purchased a new stake in shares of Abeona Therapeutics in the second quarter valued at about $190,000. Perceptive Advisors LLC bought a new position in shares of Abeona Therapeutics during the fourth quarter valued at approximately $4,085,000. Laurion Capital Management LP purchased a new stake in shares of Abeona Therapeutics in the 1st quarter worth approximately $277,000.

More notable recent Abeona Therapeutics Inc (NASDAQ:ABEO) news were published by: Zacks.com which released: "Abeona Therapeutics (ABEO) Surges: Stock Moves 22.9% Higher September 18, 2017" on September 18, 2017, also Globenewswire.com with their article: "Abeona Therapeutics and Brammer Bio Announce Collaboration for Commercial ..." published on September 28, 2017, Seekingalpha.com published: "Premarket analyst action - healthcare" on September 15, 2017. With short interest at 2,476 and short average daily volume at 9,373, days to cover is 0.0 and the percentage of shorted shares is 0.00% as of August 31. The firm's market capitalization is $728.23 million.

TRADEMARK VIOLATION NOTICE: This article was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. "(ABEO)" was posted by TrueBlueTribune and is owned by of TrueBlueTribune. It is also developing ABO-101 (AAV-NAGLU) for Sanfilippo syndrome type B (MPS IIIB), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), ABO-202 (AAV-CLN1) for treatment of infantile Batten disease (INCL), EB-201 for epidermolysis bullosa, ABO-301 (AAV-FANCC) for Fanconi anemia disorder and ABO-302 using a novel CRISPR/Cas9-based gene editing approach to gene therapy for rare blood diseases.



Like this

loading...
loading...

Latest


12 April 2018
New Jersey Looking Towards Sports Betting
New Jersey has demonstrated recently that financial returns from legalising gambling, in particular online gambling can be huge . As of April 2018 New Jersey have spent a massive $7.2M dollars in the fight to legalise sports betting within the state borders.

11 April 2018
England All-rounder David Willey Replaces Kedar Jadhav
He has two centuries and seven half centuries to his name, which have come while playing in various T20 leagues across the world. With an experience of more than 140 T20 matches, David will prove out to be the Trump Card of Chennai Super Kings this season.

08 October 2017
CVS Health Corporation (NYSE:CVS) Sees Unusual Trading Volume in Its Shares
Thomas Moriarty has seen steady activity on the sell side, and on October 2, 2017, executed an option to sell 20547 shares. Royal Bank Of Canada started coverage on shares of CVS Health Corporation in a research note on Tuesday, September 19th.

08 October 2017
Gareth Southgate: 'England have no big players'
Dele's biggest strengths are arriving in the box, timing his runs, finishing and scoring goals . In fact, he claims England's most creative player is their best player - Adam Lallana.

08 October 2017
'Justice League' Trailer Takes on the End of the World
Hence getting Joss Whedon in to finish the film and reportedly engaging in last minute reshoots to inject a couple of gags. Together, Batman and Wonder Woman work quickly to recruit a team to stand against this newly awakened enemy.

08 October 2017
Zacks Investment Research Downgrades Western Gas Equity Partners, LP (WGP) to Hold
Company trades at a P/E ratio of 34.92, and is more expensive than the average stock in the Oil & Gas Pipelines industry. Important factors to focus when evaluating a stock's present and future value are the 52 week price high and low levels.

08 October 2017
Understanding the Financial Health of National Oilwell Varco, Inc. (NYSE:NOV)
Royal Bank Of Canada reiterated a hold recommendation on stocks of National Oilwell Varco in a note on Fri, Sep 1st. COPYRIGHT VIOLATION NOTICE: This story was first published by TrueBlueTribune and is owned by of TrueBlueTribune.

08 October 2017
Newcastle training ground bust-up leaves star with broken finger
Reports surfaced on Thursday that Shelvey had broken a finger on his left hand in training after X-rays revealed the damage.

08 October 2017
Federal Bureau of Investigation says 'black identity extremists' pose growing threat to police
The FBI report was released on August 3-just nine days before a white supremacist rally in Charlottesville, Va., turned deadly. In reality, there is no "Black Identity Extremist" movement, at least not one that goes by that name.

26 September 2017
Explore Fort Tilden State Park: An Abandoned New York City
As you approach the boat graveyard, as its name is, there are about more than 100 extinct vessels that rest in the relative peace. But in the recent years, it had gone from an obscure stretch to a favorite destination among the beachgoers and lovers as well.